2009年甲型H1N1流感病毒持续感染所致严重呼吸衰竭的表面活性剂治疗与静脉注射扎那米韦 - Suppr | 超能文献

Surfactant therapy and intravenous zanamivir in severe respiratory failure due to persistent influenza A/H1N1 2009 virus infection.

作者信息

Busani Stefano, Girardis Massimo, Biagioni Emanuela, Pasetto Alberto, Sambri Vittorio

出版信息

Am J Respir Crit Care Med. 2010 Nov 15;182(10):1334. doi: 10.1164/ajrccm.182.10.1334.

DOI:10.1164/ajrccm.182.10.1334

Abstract

摘要

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

文档翻译

学术文献翻译模型，支持多种主流文档格式。

相似文献

1

Surfactant therapy and intravenous zanamivir in severe respiratory failure due to persistent influenza A/H1N1 2009 virus infection.2009年甲型H1N1流感病毒持续感染所致严重呼吸衰竭的表面活性剂治疗与静脉注射扎那米韦

Am J Respir Crit Care Med. 2010 Nov 15;182(10):1334. doi: 10.1164/ajrccm.182.10.1334.

2

Severe H1N1 infection in a pediatric liver transplant recipient treated with intravenous zanamivir: efficiency and complications.一名接受静脉注射扎那米韦治疗的小儿肝移植受者的重症甲型H1N1感染：疗效及并发症

Transplantation. 2010 Jul 27;90(2):223-4. doi: 10.1097/TP.0b013e3181e0a0df.

3

Intravenous zanamivir for patients with pneumonitis due to pandemic (H1N1) 2009 influenza virus.静脉注射扎那米韦治疗大流行（H1N1）2009 流感病毒引起的肺炎患者。

Clin Infect Dis. 2010 May 1;50(9):1249-51. doi: 10.1086/651604.

4

Acute hemorrhagic respiratory failure caused by Wegener's granulomatosis successfully treated by bronchoalveolar lavage with diluted surfactant.韦格纳肉芽肿病所致急性出血性呼吸衰竭经用稀释表面活性剂进行支气管肺泡灌洗成功治愈。

Wien Klin Wochenschr. 2003 Nov 28;115(21-22):793-6. doi: 10.1007/BF03040505.

5

Intravenous zanamivir for oseltamivir-resistant 2009 H1N1 influenza.静脉注射扎那米韦治疗对奥司他韦耐药的2009年甲型H1N1流感。

N Engl J Med. 2010 Jan 7;362(1):88-9. doi: 10.1056/NEJMc0910893. Epub 2009 Dec 23.

6

Intravenous zanamivir in critically ill patients due to pandemic 2009 (H1N1) influenza A virus.大流行 2009（H1N1）流感 A 病毒致危重症患者的静脉用扎那米韦。

Singapore Med J. 2011 Jul;52(7):481-5.

7

Therapeutic effects of exogenous surfactant enriched with dextran in newborn rabbits with respiratory failure induced by airway instillation of albumin.富含右旋糖酐的外源性表面活性剂对气道滴注白蛋白诱导的新生兔呼吸衰竭的治疗作用。

Pulm Pharmacol Ther. 2008;21(2):393-400. doi: 10.1016/j.pupt.2007.10.003. Epub 2007 Oct 18.

8

Surfactant replacement therapy in influenza A H1N1.甲型H1N1流感中的表面活性剂替代疗法。

Pediatr Infect Dis J. 2010 Apr;29(4):387. doi: 10.1097/INF.0b013e3181cf2eaa.

9

Severe H1N1-associated acute respiratory failure in immunocompromised children.免疫功能低下儿童中与严重 H1N1 相关的急性呼吸衰竭。

Pediatr Blood Cancer. 2011 Oct;57(4):625-8. doi: 10.1002/pbc.22973. Epub 2011 Feb 4.

10

Efficient control of pandemic 2009 H1N1 virus infection with intravenous zanamivir despite the lack of immune function.尽管缺乏免疫功能，但静脉注射扎那米韦仍能有效控制2009年甲型H1N1流感大流行病毒感染。

Transpl Infect Dis. 2012 Dec;14(6):657-9. doi: 10.1111/tid.12004. Epub 2012 Sep 26.

引用本文的文献

1

Lethal H1N1 influenza A virus infection alters the murine alveolar type II cell surfactant lipidome.致死性甲型H1N1流感病毒感染会改变小鼠肺泡II型细胞表面活性物质脂质组。

Am J Physiol Lung Cell Mol Physiol. 2016 Dec 1;311(6):L1160-L1169. doi: 10.1152/ajplung.00339.2016. Epub 2016 Nov 11.